0 Introduction and background: The complete idea of "green supply chain management" or GSCM was initially stated by the (MRC) Manufacturing Research consortium at Michigan University of the United States in 1997. Green production network in pharmaceutical is wherever pharmaceutical solutions are made and expended. Pharmaceutical is a sector which isamong one of the most organized sectors of Pakistan. For Pharmaceutical industry, Counterfeiting is a major concern. Counterfeit medicines are which
Words: 6928 - Pages: 28
University, Pakistan Pharmaceutical marketing mix strategy and physician’s prescription behavior Rizwan Raheem Ahmed ABSTRACT Purpose: This research paper gives an insight about the processes used by local and MNCs pharmaceutical companies in Pakistan.The purpose of our research is to examine that what factors affect physician prescription behavior based on ethical grounds. Methodology: This research focuses on the strategies and marketing tools used by pharmaceutical companies in Pakistan, and
Words: 3490 - Pages: 14
Pharmaceutical Industry: New Drug Development Semester: 2012 Day of Week/Time: Office Hours: Class Website: Overview This course provides a detailed overview of the drug and biologics development process from discovery through regulatory approval. Special attention is given to the roles, functions and significance of the various disciplines involved in the R&D process, their interactions with each other, and the strategic management of these functions. Attention will also
Words: 2063 - Pages: 9
aberidoost et al. DARU Journal of Pharmaceutical Sciences 2013, 21:69 http://www.darujps.com/content/21/1/69 REVIEW ARTICLE Open Access Pharmaceutical supply chain risks: a systematic review Mona Jaberidoost1, Shekoufeh Nikfar1, Akbar Abdollahiasl1,2 and Rassoul Dinarvand1,3* Abstract Introduction: Supply of medicine as a strategic product in any health system is a top priority. Pharmaceutical companies, a major player of the drug supply chain, are subject to many risks. These risks disrupt
Words: 4846 - Pages: 20
ANALYSIS OF SUPPLY CHAIN RISK MANAGEMENT IN THE GHANAIAN MANUFACTURING INDUSTRY: A CASE STUDY OF KAMA PHARMACEUTICAL MANUFACTURING COMPANY INTRODUCTION 1.0 Background of the Study According to Hendricks and Singhal (2005), there is increased awareness and recognition among managers, consultants and academicians that supply chain performance is increasingly important to business success. In other words, supply chain plays an important strategic role in the world economy and that firms are
Words: 8147 - Pages: 33
Pharmaceutical Supply Chain Abstract • The global pharmaceutical supply chain is very complex and critical to a $650 billion dollar value industry which ensures the world population has necessary medicines. • Manufacturers have the responsibility to produce sufficient quantities of drugs to meet a growing global demand while maintaining quality to ensure safety. • Global and local regulatory agencies around the world have a daunting task to monitor manufacturers, raw material suppliers, and stem
Words: 6177 - Pages: 25
al., 2013 ISSN 2319-345X www.ijmrbs.com Vol. 2, No. 1, January 2013 © 2013 IJMRBS. All Rights Reserved APPLICATION OF LEAN AND JIT PRINCIPLES IN SUPPLY CHAIN MANAGEMENT Chandan Deep Singh1, Rajdeep Singh1, Jaskanwal Singh Mand1* and Sukhvir Singh1 *Corresponding Author: Jaskanwal Singh Mand, mandjaskanwal@yahoo.com Supply Chain Management is a set of synchronized decisions and activities utilized to efficiently integrate suppliers, manufacturers, warehouses, transporters, retailers
Words: 6899 - Pages: 28
Online resources Contact Us Here you are: The Lawyers & Jurists > resources > Industries > Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. view with images and charts Supply Chain Management SYSTEMS of SQUARE PHARMACEUTICALS LTD. Introduction: Formally designed Commercial Department has been renamed as “Supply Chain Management” (SCM) in Mid July 2007. When only one Manager was guiding as Head of the Department
Words: 8546 - Pages: 35
1. Introduction to the Industry and Company 1.1 Industry Overview The Australian pharmaceutical market in which MYX compete is a technology-intensive, knowledge-based one which “comprises bio-medical research, biotechnology firms, originator and generic medicines companies and service-related segments including wholesaling and distribution” (Department of Industry n.d.a). In order to assess the investment prospect of the industry, a Porter’s Five Force analysis is conducted (see reference list for
Words: 783 - Pages: 4
The Global Pharmaceutical Industry Case Analysis This case by Sarah Holland and Bernardo Bátiz-Lazostudies studies the evolution of the ethical pharmaceutical industry and analyses the various forces affecting the discovery, development, production, distribution and marketing of prescription drugs. The authors further analyses the critical issues of corporate social responsibility in the industry and the strategies being followed by major pharmaceutical companies and the challenges and opportunities
Words: 6162 - Pages: 25
